The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)

NCT04166838 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia (B-ALL)
Safety and Efficacy of CD19 UCAR-T Cells

Interventions

BIOLOGICAL: CD19 UCARTcells

Sponsor

Shanghai Longyao Biotechnology Inc., Ltd.